Capula Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
4,682
+2,373
| +103% | +$110K | ﹤0.01% | 144 |
|
|
2025
Q1 | $141K | Buy |
+2,309
| New | +$141K | ﹤0.01% | 296 |
|
|
2024
Q4 | – | Sell |
-17,276
| Closed | -$894K | – | 263 |
|
|
2024
Q3 | $894K | Buy |
+17,276
| New | +$894K | 0.01% | 101 |
|
|
2023
Q3 | – | Sell |
-70,603
| Closed | -$4.52M | – | 331 |
|
|
2023
Q2 | $4.52M | Sell |
70,603
-842
| -1% | -$53.8K | 0.11% | 16 |
|
|
2023
Q1 | $4.95M | Sell |
71,445
-153,868
| -68% | -$10.7M | 0.06% | 25 |
|
|
2022
Q4 | $16.2M | Buy |
+225,313
| New | +$16.2M | 0.22% | 11 |
|
|
2022
Q3 | – | Sell |
-1,023
| Closed | -$79K | – | 306 |
|
|
2022
Q2 | $79K | Buy |
+1,023
| New | +$79K | ﹤0.01% | 91 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 63 |
|
|
2021
Q4 | – | Sell |
-33,586
| Closed | -$1.99M | – | 98 |
|
|
2021
Q3 | $1.99M | Buy |
33,586
+16,322
| +95% | +$966K | 0.02% | 138 |
|
|
2021
Q2 | $1.15M | Buy |
17,264
+13,846
| +405% | +$918K | 0.02% | 76 |
|
|
2021
Q1 | $216K | Sell |
3,418
-6,785
| -67% | -$429K | ﹤0.01% | 126 |
|
|
2020
Q4 | $633K | Buy |
+10,203
| New | +$633K | 0.03% | 44 |
|
|
2020
Q3 | – | Sell |
-95,558
| Closed | -$5.62M | – | 47 |
|
|
2020
Q2 | $5.62M | Sell |
95,558
-25,566
| -21% | -$1.5M | 0.2% | 8 |
|
|
2020
Q1 | $6.75M | Buy |
+121,124
| New | +$6.75M | 0.24% | 27 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 102 |
|